Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Top Cited Papers
- 1 October 2019
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 200 (7), e45-e67
- https://doi.org/10.1164/rccm.201908-1581st
Abstract
Background: This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia. Methods: A multidisciplinary panel conducted pragmatic systematic reviews of the relevant research and applied Grading of Recommendations, Assessment, Development, and Evaluation methodology for clinical recommendations. Results: The panel addressed 16 specific areas for recommendations spanning questions of diagnostic testing, determination of site of care, selection of initial empiric antibiotic therapy, and subsequent management decisions. Although some recommendations remain unchanged from the 2007 guideline, the availability of results from new therapeutic trials and epidemiological investigations led to revised recommendations for empiric treatment strategies and additional management decisions. Conclusions: The panel formulated and provided the rationale for recommendations on selected diagnostic and treatment strategies for adult patients with community-acquired pneumonia.Keywords
This publication has 214 references indexed in Scilit:
- A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumoniaBMC Infectious Diseases, 2013
- Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial PneumoniaAntimicrobial Agents and Chemotherapy, 2013
- Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPublished by Wiley ,2012
- Cethromycin versus Clarithromycin for Community-Acquired Pneumonia: Comparative Efficacy and Safety Outcomes from Two Double-Blinded, Randomized, Parallel-Group, Multicenter, Multinational Noninferiority StudiesAntimicrobial Agents and Chemotherapy, 2012
- Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired PneumoniaAntimicrobial Agents and Chemotherapy, 2010
- Outcomes of adults hospitalised with severe influenzaThorax, 2010
- Diagnosis of Pulmonary Malignancy after Hospitalization for PneumoniaAmerican Journal Of Medicine, 2010
- Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia*Critical Care Medicine, 2009
- Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trialJournal of General Internal Medicine, 2006
- Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind studyBMJ, 2006